Does PONATINIB Cause Graft versus host disease? 132 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 132 reports of Graft versus host disease have been filed in association with PONATINIB (Iclusig). This represents 1.3% of all adverse event reports for PONATINIB.
132
Reports of Graft versus host disease with PONATINIB
1.3%
of all PONATINIB reports
26
Deaths
69
Hospitalizations
How Dangerous Is Graft versus host disease From PONATINIB?
Of the 132 reports, 26 (19.7%) resulted in death, 69 (52.3%) required hospitalization, and 3 (2.3%) were considered life-threatening.
Is Graft versus host disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PONATINIB. However, 132 reports have been filed with the FAERS database.
What Other Side Effects Does PONATINIB Cause?
Death (1,735)
Off label use (1,071)
Product dose omission issue (817)
Fatigue (687)
Rash (639)
Headache (553)
Pyrexia (542)
Nausea (466)
Hospitalisation (459)
Constipation (435)
What Other Drugs Cause Graft versus host disease?
CYCLOSPORINE (1,131)
TACROLIMUS (900)
MYCOPHENOLATE MOFETIL (890)
CYCLOPHOSPHAMIDE (653)
METHOTREXATE (615)
FLUDARABINE (541)
BUSULFAN (507)
RUXOLITINIB (469)
METHYLPREDNISOLONE (429)
PREDNISONE (405)
Which PONATINIB Alternatives Have Lower Graft versus host disease Risk?
PONATINIB vs PONATINIB\PONATINIB
PONATINIB vs PONESIMOD
PONATINIB vs PORACTANT ALFA
PONATINIB vs PORFIMER
PONATINIB vs POSACONAZOLE